Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
Go back to Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program| (NASDAQ: KALA) | Delayed: 0.54 -0.02 (3.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.56 | 52 Week High | $ | |||
| Open | $0.55 | 52 Week Low | $ | |||
| Day High | $0.58 | P/E | N/A | |||
| Day Low | $0.53 | EPS | $ | |||
| Volume | 81,739 | |||||

